|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Conclusions:</b> Our findings implied that LINC00963/miR-204-3p/FN1 can play an important role in proliferation and progression in osteosarcoma.
|
30975024 |
2019 |
|
Osteosarcoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, correlations of FN and αvβ3 with the clinicopathological features of osteosarcoma patients were analyzed using the χ<sup>2</sup> test and Fisher's exact test.
|
30691475 |
2019 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, these results indicated the role and potential application of the lncRNA OIP5-AS1/miR-200b-3p/FN1 regulatory pathway as a promising target in treatment of OS chemo-resistance.
|
30204936 |
2019 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cellular fibronectin can be purified from an osteosarcoma fibroblast cell line by affinity chromatography using a monoclonal antibody anti-fibronectin as ligand.
|
28836210 |
2017 |
|
Osteosarcoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our present study revealed that visfatin can significantly promote the in vitro migration and invasion of osteosarcoma MG-63 and HOS cells and up regulate the expression of matrix metalloproteinase-2 (MMP-2) and fibronectin (FN).
|
27568842 |
2016 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
It was found that osteosarcoma cells demonstrated maximal binding to fibronectin-coated HA, while MSCs alternately preferred HA coated with collagen-I.
|
18626747 |
2008 |
|
Osteosarcoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate the expression pattern of fibronectin splice variants in bone cell lines and in different human bone tissue samples (mature bone, early stages of fracture healing, hypotrophic nonunion, osteosarcoma).
|
15589214 |
2004 |
|
Osteosarcoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This study shows that (1) gene expression pattern in osteosarcoma cell lines differs considerably from normal osteoblasts, (2) osteosarcoma cell lines can be used as a model system to detect novel gene expression alterations present in primary tumors, (3) the overexpression of heat shock protein 90beta and polyadenylate-binding protein-like 1, and (4) the down-regulation of fibronectin 1 and thrombospondin 1 may play a role in the development and/or progression of osteosarcoma.
|
11156738 |
2000 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, transient overexpression of Edg-2 sensitized MG63 human osteosarcoma cells to both LPA- and S1P-mediated stimulation of fibronectin matrix deposition and actin stress fiber formation.
|
10961347 |
2000 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Addition of S1P to human osteosarcoma MG63 cells or human foreskin fibroblasts increased cell-mediated binding and assembly of fibronectin.
|
10216094 |
1999 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Binding of labeled FN to receptor-rich MG63 human osteosarcoma cells was inhibited by the hexapeptide.
|
2963329 |
1988 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
FN mRNA, as measured by Northern blot hybridization, increased within 6 h of 1,25-(OH)2D3 addition with maximal (5-fold) induction seen at 24 h. 1,25-(OH)2D3 also stimulated FN synthesis in several other transformed cell lines (TE-85 human osteosarcomas, SW-480 human colon carcinomas, and HL-60 myeloid leukemia cells).
|
3470294 |
1987 |
|
Osteosarcoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
MG-63 human osteosarcoma cells were selected for attachment and growth in the presence of increasing concentrations of a synthetic peptide containing the cell attachment-promoting Arg-Gly-Asp sequence derived from the cell-binding region of fibronectin.
|
2443508 |
1987 |